Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Notices 723 

calibrating international standards. The 

Board welcomes feedback on current 

and future QISs from firms both 

formally, through frequently asked 

questions (FAQs), and informally via 

newly instituted QIS outreach sessions, 

ad hoc discussions, and emails. As a 

general matter, however, the Board is 

unable to guarantee the release of QISs 

for notice and comment because 

international working groups often 

require three or more months to develop 

QISs, and the typical timeframe for the 

entire QIS process is six months. The 

full notice-and-comment period under 

the PRA for information collections is 

60 days. In order to alter such a 

proposed QIS prior to its finalization, 

the international working groups that 

develop the QIS would need to 

reconvene and the development process 

would need to be reopened. Given these 

constraints, the Board may have 

insufficient time to conduct the final 

survey and analyze the results within 

the typical six-month QIS timeframe. 

However, when a QIS template is 

available in advance of the planned 

distribution date, the Board works to 

distribute the templates to respondents 

early for information purposes, and 

when time allows, to obtain feedback. 

The Board has sent several proposed 

collections to firms for feedback in 

advance of the due date, including the 

end-December 2017 Basel Monitoring 

collection, and the newly proposed 

Basel III Monitoring Capital and 

Liquidity collections. Upon receiving 

feedback from firms, the Board, in 

conjunction with the Basel Committee 

QIS working group, often revises the 

templates and applies the feedback to 

subsequent templates in order to 

enhance the relevance and quality of 

collected data. 

The commenter’s final 

recommendation was for the Board to 

recognize QIS data limitations when 

applying international standards to U.S. 

institutions. The commenter noted the 

example of a QIS for the largest 

financial institutions in connection with 

Basel III, arguing that it did not capture 

the impact of the proposals on all 

segments of the U.S. banking sector, its 

customers, and the broader U.S. 

economy. The Board recognizes the 

limitations of QIS data and confirms 

that QISs are a tool that serves as a 

starting point for assessing the impact of 

proposals. 

The information collection will be 

extended without revision as proposed. 

Board of Governors of the Federal Reserve 

System, January 17, 2019. 

Michele Taylor Fennell, 

Assistant Secretary of the Board. 

[FR Doc. 2019–00366 Filed 1–30–19; 8:45 am] 

BILLING CODE 6210–01–P 

GENERAL SERVICES 

ADMINISTRATION 

[Notice–WSCC–2019–01; Docket 2019–0004; 

Sequence No. 1] 

Women’s Suffrage Centennial 

Commission; Notification of Public 

Meeting 

AGENCY: Women’s Suffrage Centennial 

Commission, General Services 

Administration (GSA). 

ACTION: Meeting notice. 

SUMMARY: Notice of this meeting is being 

provided according to the requirements 

of the Federal Advisory Committee Act. 

This notice provides the schedule and 

agenda for the February meeting of the 

Women’s Suffrage Centennial 

Commission (Commission). The meeting 

is open to the public. 

DATES: Meeting date: The meeting will 

be held on Wednesday, February 27, 

2019, beginning at 9:00 a.m. (Eastern 

Standard Time), and ending no later 

than 5:00 p.m., EST. 

ADDRESSES: The meeting will be held at 

the National Archives, 700 

Pennsylvania Avenue NW, Washington, 

DC 20408. In the event that the partial 

lapse in appropriations shutdown is still 

in effect, the meeting will still be held 

on the scheduled date, February 27, 

2019, but the contingency location will 

be: Library of Congress, Madison 

Building, 101 Independence Ave. SE, 

Washington, DC 20540, Sixth Floor, 

Dining Room A. 

FOR FURTHER INFORMATION CONTACT: 

Rebecca Kleefisch, Executive Director, 

Women’s Suffrage Centennial 

Commission, P.O. Box 2020, 

Washington, DC 20013; email: rebecca@

womensvote100.org; telephone: 262– 

349–2990. 

SUPPLEMENTARY INFORMATION: 

Background 

Congress passed legislation to create 

the Women’s Suffrage Centennial 

Commission Act, a bill, ‘‘to ensure a 

suitable observance of the centennial of 

the passage and ratification of the 19th 

Amendment of the Constitution of the 

United States providing for women’s 

suffrage.’’ 

The duties of the Commission, as 

written in the law, include: (1) To 

encourage, plan, develop, and execute 

programs, projects, and activities to 

commemorate the centennial of the 

passage and ratification of the 19th 

Amendment; (2) To encourage private 

organizations and State and local 

Governments to organize and participate 

in activities commemorating the 

centennial of the passage and 

ratification of the 19th Amendment; (3) 

To facilitate and coordinate activities 

throughout the United States relating to 

the centennial of the passage and 

ratification of the 19th Amendment; (4) 

To serve as a clearinghouse for the 

collection and dissemination of 

information about events and plans for 

the centennial of the passage and 

ratification of the 19th Amendment; and 

(5) To develop recommendations for 

Congress and the President for 

commemorating the centennial of the 

passage and ratification of the 19th 

Amendment. 

Meeting Agenda 

b Welcome 

b Approval of Minutes 

b Update on WSCC personnel 

b Update on WSCC activities 

b Adjourn 

The meeting is open to the public, but 

preregistration is required. Any 

individual who wishes to attend the 

meeting should register via email at 

rebecca@womensvote100.org; 

Individuals requiring special 

accommodations to access the public 

meeting should contact Rebecca 

Kleefisch no later than Monday, 

February 18, 2019, so that appropriate 

arrangements can be made. Interested 

persons may choose to make a public 

comment at the meeting during the 

designated time for this purpose. 

Members of the public may also choose 

to submit written comments by mailing 

them to Rebecca Kleefisch, Executive 

Director, Women’s Suffrage Centennial 

Commission, P.O. Box 2020, 

Washington, DC 20013; or by emailing 

rebecca@womensvote100.org. 

Please contact Rebecca Kleefisch at 

the email address above to obtain 

meeting materials. All written 

comments received will be provided to 

the Commission. 

Public Disclosure of Comments 

Before including your address, phone 

number, email address, or other 

personal identifying information in your 

comment, you should be aware that 

your entire comment—including your 

personal identifying information—may 

be made publicly available at any time. 

While you can ask us in your comment 

to withhold your personal identifying 

information from public review, we 


amozie on DSK3GDR082PROD with NOTICES1
724 Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Notices 

cannot guarantee that we will be able to 

do so. 

Dated: January 25, 2019. 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide 

Policy, General Services Administration. 

[FR Doc. 2019–00296 Filed 1–30–19; 8:45 am] 

BILLING CODE 3420–37–P 

GOVERNMENT ACCOUNTABILITY 

OFFICE 

Request for Medicare Payment 

Advisory Commission (MedPAC) 

Nominations 

AGENCY: U.S. Government 

Accountability Office (GAO). 

ACTION: Request for letters of 

nomination and resumes. 

SUMMARY: The Balanced Budget Act of 

1997 established the Medicare Payment 

Advisory Commission (MedPAC) and 

gave the Comptroller General 

responsibility for appointing its 

members. GAO is now accepting 

nominations for MedPAC appointments 

that will be effective May 2019. 

Nominations should be sent to the email 

or mailing address listed below. 

Acknowledgement of submissions will 

be provided within a week of 

submission. 

DATES: Letters of nomination and 

resumes should be submitted no later 

than March 8, 2019, to ensure adequate 

opportunity for review and 

consideration of nominees prior to 

appointment. 

ADDRESSES: Submit letters of 

nomination and resumes by either of the 

following methods: Email: 

MedPACappointments@gao.gov or Mail: 

U.S. GAO, Attn: MedPAC 

Appointments, 441 G Street NW, 

Washington, DC 20548. 

FOR FURTHER INFORMATION CONTACT: Will 

Black at (202) 512–6482 or blackw@

gao.gov if you do not receive an 

acknowledgement or need additional 

information. For general information, 

contact GAO’s Office of Public Affairs, 

(202) 512–4800. 

Authority: 42 U.S.C. 1395b–6. 

Gene L. Dodaro, 

Comptroller General of the United States. 

[FR Doc. 2019–00571 Filed 1–30–19; 8:45 am] 

BILLING CODE 1610–02–P 

GOVERNMENT ACCOUNTABILITY 

OFFICE 

Request for Medicaid and CHIP 

Payment and Access Commission 

(MACPAC) Nominations 

AGENCY: U.S. Government 

Accountability Office (GAO). 

ACTION: Request for letters of 

nomination and resumes. 

SUMMARY: The Children’s Health 

Insurance Program Reauthorization Act 

of 2009 (CHIPRA) established MACPAC 

to review Medicaid and CHIP access 

and payment policies and to advise 

Congress on issues affecting Medicaid 

and CHIP. CHIPRA gave the Comptroller 

General of the United States 

responsibility for appointing MACPAC’s 

members. GAO is now accepting 

nominations for MACPAC appointments 

that will be effective May 1, 2019. 

Nominations should be sent to the email 

or mailing address listed below. 

Acknowledgement of submissions will 

be provided within a week of 

submission. 

DATES: Letters of nomination and 

resumes should be submitted no later 

than February 20, 2019, to ensure 

adequate opportunity for review and 

consideration of nominees prior to 

appointment. 

ADDRESSES: Submit letters of 

nomination and resumes by either of the 

following methods: Email: 

MACPACappointments@gao.gov or 

Mail: U.S. GAO, Attn: MACPAC 

Appointments, 441 G Street NW, 

Washington, DC 20548. 

FOR FURTHER INFORMATION CONTACT: 

Susan Anthony at (312) 220–7666 or 

anthonys@gao.gov if you do not receive 

an acknowledgment or need additional 

information. For general information, 

contact GAO’s Office of Public Affairs, 

(202) 512–4800. 

Authority: Public Law 111–3, sec. 506; 42 

U.S.C. 1396. 

Gene L. Dodaro, 

Comptroller General of the United States. 

[FR Doc. 2019–00572 Filed 1–30–19; 8:45 am] 

BILLING CODE 1610–02–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Guidance Regarding Agency 

Interpretation of ‘‘Rabies-Free’’ as It 

Relates to the Importation of Dogs Into 

the United States 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of agency guidance. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) in the 

Department of Health and Human 

Services (HHS) is publishing this 

guidance for dog owners and importers 

who seek to admit a dog without a valid 

rabies vaccination certificate into the 

United States. Under current 

regulations, all dogs admitted into the 

United States must be accompanied by 

a valid rabies vaccination certificate 

unless the dog’s owner or importer 

submits satisfactory evidence that the 

dog has only been in a rabies-free 

country if it is less than 6 months old 

or has only been in a rabies-free country 

for the 6 months before arrival if it is 

older than 6 months. Through this 

guidance, CDC is clarifying that it 

interprets ‘‘rabies-free’’ for the purposes 

of dog importation to mean ‘‘canine 

rabies virus variant (CRVV)-free.’’ For 

all other public health purposes, CDC 

will continue to apply the general 

definition of ‘‘rabies free,’’ which 

includes and reflects the rabies status of 

all terrestrial animals and not just dogs. 

This guidance further describes the 

considerations taken into account by 

experts in determining whether a 

country qualifies as CRVV-free. This 

notice also informs dog owners and 

importers on where to locate up-to-date 

information on a country’s CRVV status 

to facilitate a dog’s entry or re-entry into 

the United States. 

DATES: This guidance will be 

implemented on January 31, 2019. 

FOR FURTHER INFORMATION CONTACT: 

For information regarding this notice 

contact: Ashley A. Altenburger, J.D., 

Division of Global Migration and 

Quarantine, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

MS–H16–4, Atlanta, GA 30329. 

For information regarding CDC 

operations related to this notice contact: 

Kendra Stauffer, D.V.M., Division of 

Global Migration and Quarantine, 

Centers for Disease Control andPrevention, 1600 Clifton Road NE, MS– 

V–18–2, Atlanta, GA 30329. Either 

person may also be reached by 


amozie on DSK3GDR082PROD with NOTICES1